Roivant Sciences Ltd. (ROIV)
41.43
+6.50
(+18.61%)
USD |
NASDAQ |
Sep 08, 15:59
41.30
-0.13
(-0.31%)
After-Hours: 20:00
Roivant Sciences Total Assets (Quarterly) : 5.306B for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 5.306B |
| March 31, 2026 | 5.728B |
| December 31, 2025 | 5.225B |
| September 30, 2025 | 5.063B |
| June 30, 2025 | 5.033B |
| March 31, 2025 | 5.437B |
| December 31, 2024 | 5.792B |
| September 30, 2024 | 6.206B |
| June 30, 2024 | 6.496B |
| March 31, 2024 | 7.222B |
| December 31, 2023 | 7.313B |
| September 30, 2023 | 2.066B |
| June 30, 2023 | 2.137B |
| Date | Value |
|---|---|
| March 31, 2023 | 2.390B |
| December 31, 2022 | 2.203B |
| September 30, 2022 | 2.216B |
| June 30, 2022 | 2.600B |
| March 31, 2022 | 2.585B |
| December 31, 2021 | 2.799B |
| September 30, 2021 | 3.103B |
| June 30, 2021 | 2.555B |
| March 31, 2021 | 2.690B |
| December 31, 2020 | |
| September 30, 2020 | |
| June 30, 2020 | |
| March 31, 2020 | 2.477B |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Oxford Biomedica Plc | -- |
| Bicycle Therapeutics Plc | 606.58M |
| Arbutus Biopharma Corp. | 274.02M |
| Moderna, Inc. | 10.96B |
| Adaptimmune Therapeutics Plc | 130.63M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 384.62M |
| Shareholders Equity (Quarterly) | 4.231B |
| Debt to Equity Ratio | 0.0253 |
| Current Ratio | 16.72 |
| Net Debt Paydown Yield | -0.01% |